| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
|
Sun, MengJiao
|
|
|
51 |
C |
p.
|
artikel
|
| 2 |
A case of longitudinally extensive transverse myelitis in an 80-year-old patient with systemic lupus erythematous and anti-aquaporin 4 antibodies
|
Pirro, F.
|
|
|
51 |
C |
p.
|
artikel
|
| 3 |
Alemtuzumab in Covid era
|
Iovino, Aniello
|
|
|
51 |
C |
p.
|
artikel
|
| 4 |
A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers
|
Edwards, Keith R.
|
|
|
51 |
C |
p.
|
artikel
|
| 5 |
A pilot randomized controlled trial of robotic exoskeleton-assisted exercise rehabilitation in multiple sclerosis
|
Androwis, Ghaith J.
|
|
|
51 |
C |
p.
|
artikel
|
| 6 |
‘A sleeping volcano that could erupt sooner or later’. Lived experiences of women with multiple sclerosis during childbearing age and motherhood: A phenomenological qualitative study
|
Colaceci, Sofia
|
|
|
51 |
C |
p.
|
artikel
|
| 7 |
Atypical inflammatory demyelinating syndrome with central and peripheral nerve involvement
|
Farag, Mena
|
|
|
51 |
C |
p.
|
artikel
|
| 8 |
Comparative effectiveness of psychotherapy approaches on Death Anxiety in Multiple Sclerosis Patients. A pilot randomized controlled trial
|
Lotfifar, Behnam
|
|
|
51 |
C |
p.
|
artikel
|
| 9 |
Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study
|
Piasecka-Stryczynska, Karolina
|
|
|
51 |
C |
p.
|
artikel
|
| 10 |
Corpus callosum lesions are not inextricably linked to CNS symptoms in reported cases of susac syndrome
|
Paton, Gillian R
|
|
|
51 |
C |
p.
|
artikel
|
| 11 |
COVID-19 and emerging spinal cord complications: A systematic review
|
Mondal, Ritwick
|
|
|
51 |
C |
p.
|
artikel
|
| 12 |
COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
|
Etemadifar, Masoud
|
|
|
51 |
C |
p.
|
artikel
|
| 13 |
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America
|
Alonso, Ricardo
|
|
|
51 |
C |
p.
|
artikel
|
| 14 |
COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update
|
Jack, Dominic
|
|
|
51 |
C |
p.
|
artikel
|
| 15 |
Depression in multiple sclerosis: Is one approach for its management enough?
|
Jones, C. Danielle
|
|
|
51 |
C |
p.
|
artikel
|
| 16 |
Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis
|
Mayo, Chantel D.
|
|
|
51 |
C |
p.
|
artikel
|
| 17 |
Digital biomarkers can highlight subtle clinical differences in radiologically isolated syndrome compared to healthy controls
|
Cohen, Mikael
|
|
|
51 |
C |
p.
|
artikel
|
| 18 |
Do baseline cognitive status, participant specific characteristics and EDSS impact changes of cognitive performance following aerobic exercise intervention in multiple sclerosis?
|
Rademacher, Annette
|
|
|
51 |
C |
p.
|
artikel
|
| 19 |
Effects of low vs. high frequency local vibration on mild-moderate muscle spasticity: Ultrasonographical and functional evaluation in patients with multiple sclerosis
|
Ayvat, Fatma
|
|
|
51 |
C |
p.
|
artikel
|
| 20 |
Effects on gait and balance of home-based active video game interventions in persons with multiple sclerosis: A systematic review
|
Dalmazane, Marion
|
|
|
51 |
C |
p.
|
artikel
|
| 21 |
Electronic pill bottle monitoring versus reminders to promote medication adherence for people with multiple sclerosis: A randomized, virtual clinical trial
|
Rice, Dylan R.
|
|
|
51 |
C |
p.
|
artikel
|
| 22 |
Epstein–Barr virus infection causes inflammation in the brain in a rabbit model
|
Hassani, Asma
|
|
|
51 |
C |
p.
|
artikel
|
| 23 |
Failure of IVIG in steroid-responsive autoimmune glial fibrillary acidic protein astrocytopathy: A case report
|
Heide, Elena S.
|
|
|
51 |
C |
p.
|
artikel
|
| 24 |
First report of HHV-8 viral load and seroprevalence of major blood-borne viruses in Iranian patients with systemic sclerosis
|
Hashempour, Ava
|
|
|
51 |
C |
p.
|
artikel
|
| 25 |
Fulminant ADEM treated with cyclophosphamide: Case report and review of the literature
|
Anderson, Dustin
|
|
|
51 |
C |
p.
|
artikel
|
| 26 |
How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey
|
Morrison, Elizabeth H.
|
|
|
51 |
C |
p.
|
artikel
|
| 27 |
Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy
|
Jonakowski, M.
|
|
|
51 |
C |
p.
|
artikel
|
| 28 |
Integrating patient-reported outcomes and quantitative timed tasks to identify relapsing remitting multiple sclerosis patient subgroups: a latent profile analysis
|
Briggs, Farren B.S.
|
|
|
51 |
C |
p.
|
artikel
|
| 29 |
Is natalizumab a safe treatment for patients with multiple sclerosis in the COVID-19 pandemic? Data from the first year of the pandemic
|
Díaz-Díaz, Judit
|
|
|
51 |
C |
p.
|
artikel
|
| 30 |
Low-field portable brain MRI in CNS demyelinating disease
|
Mateen, Farrah J.
|
|
|
51 |
C |
p.
|
artikel
|
| 31 |
Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis
|
Ge, Fan
|
|
|
51 |
C |
p.
|
artikel
|
| 32 |
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia
|
Al Jumah, Mohammed
|
|
|
51 |
C |
p.
|
artikel
|
| 33 |
Melatonin and multiple sclerosis
|
Hawkes, Christopher H
|
|
|
51 |
C |
p.
|
artikel
|
| 34 |
Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light
|
Orsi, Gergely
|
|
|
51 |
C |
p.
|
artikel
|
| 35 |
Middle-age people with multiple sclerosis demonstrate similar mobility characteristics to neurotypical older adults
|
Swanson, Clayton W.
|
|
|
51 |
C |
p.
|
artikel
|
| 36 |
MS and Disability Progression in Latin America, Africa, Asia and the Middle East: A Systematic Review
|
Bonomi, Samuele
|
|
|
51 |
C |
p.
|
artikel
|
| 37 |
Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: Potential association between demyelination and tumor necrosis factor inhibitors
|
Luo, Wenjng
|
|
|
51 |
C |
p.
|
artikel
|
| 38 |
Neutrophil-lymphocyte ratio as a marker for disability and activity in multiple sclerosis
|
Fahmi, Rasha M.
|
|
|
51 |
C |
p.
|
artikel
|
| 39 |
No evidence of disease activity-3 (NEDA-3) status in patients with relapsing remitting multiple sclerosis: Evidence from Saudi cohort receiving mainly Interferon.
|
Zafar, Azra
|
|
|
51 |
C |
p.
|
artikel
|
| 40 |
Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis
|
Chu, Duong T.
|
|
|
51 |
C |
p.
|
artikel
|
| 41 |
Outcomes of COVID-19 in people with multiple sclerosis treated with cladribine tablets: an update
|
Jack, Dominic
|
|
|
51 |
C |
p.
|
artikel
|
| 42 |
Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program
|
Selmaj, Krzysztof W.
|
|
|
51 |
C |
p.
|
artikel
|
| 43 |
“Peppering the pons”: CLIPPERS or myelin oligodendrocyte glycoprotein associated disease?
|
Obeidat, Ahmed Z.
|
|
|
51 |
C |
p.
|
artikel
|
| 44 |
Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries
|
Viktoria, Papp
|
|
|
51 |
C |
p.
|
artikel
|
| 45 |
Predominant cognitive phenotypes in multiple sclerosis: Insights from patient-centered outcomes
|
Podda, Jessica
|
|
|
51 |
C |
p.
|
artikel
|
| 46 |
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort study
|
Huttner, Angela
|
|
|
51 |
C |
p.
|
artikel
|
| 47 |
Randomized controlled trials for neuromyelitis optica spectrum disorder: a systematic review of trial architecture
|
Cabal-Herrera, Ana Maria
|
|
|
51 |
C |
p.
|
artikel
|
| 48 |
Rate, burden, and treatment of sexual dysfunction in multiple sclerosis: The case for exercise training as a new treatment approach
|
Sadeghi Bahmani, Dena
|
|
|
51 |
C |
p.
|
artikel
|
| 49 |
Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis
|
Reder, Anthony T
|
|
|
51 |
C |
p.
|
artikel
|
| 50 |
Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatment
|
Pantazou, Vasiliki
|
|
|
51 |
C |
p.
|
artikel
|
| 51 |
Relevance of the Bulgarian SmartMS system to regional real-world data analysis in patients with multiple sclerosis
|
Ovcharova, Emiliya
|
|
|
51 |
C |
p.
|
artikel
|
| 52 |
Response to hepatitis B vaccine in patients with multiple sclerosis: preliminary data
|
Redondo, Moisés Garcés
|
|
|
51 |
C |
p.
|
artikel
|
| 53 |
Restless Legs Syndrome in Multiple Sclerosis: Risk factors and effect on sleep quality – a case-control study
|
Monschein, Tobias
|
|
|
51 |
C |
p.
|
artikel
|
| 54 |
Risk factors for COVID-19 infection in patients with multiple sclerosis: a nested case–control study
|
Uhr, Lauren
|
|
|
51 |
C |
p.
|
artikel
|
| 55 |
Rituximab for refractory primary angiitis of the central nervous system: Experience in two patients
|
Paramasivan, Naveen Kumar
|
|
|
51 |
C |
p.
|
artikel
|
| 56 |
Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series
|
Kaya Tutar, Nurhan
|
|
|
51 |
C |
p.
|
artikel
|
| 57 |
Seeing the invisible: an exploration of living with, and managing the invisible symptoms of multiple sclerosis
|
Parker, Le-Sharn
|
|
|
51 |
C |
p.
|
artikel
|
| 58 |
Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
|
Melnikov, Mikhail
|
|
|
51 |
C |
p.
|
artikel
|
| 59 |
Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics
|
Ghonimi, Nesma A.M.
|
|
|
51 |
C |
p.
|
artikel
|
| 60 |
Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity.
|
De Blasiis, Paolo
|
|
|
51 |
C |
p.
|
artikel
|
| 61 |
Smartphone applications to assess gait and postural control in people with multiple sclerosis: A systematic review
|
Abou, Libak
|
|
|
51 |
C |
p.
|
artikel
|
| 62 |
Spinal cord involvement in LHON requires pathophysiological clarification
|
Finsterer, J
|
|
|
51 |
C |
p.
|
artikel
|
| 63 |
Stressful life events and the risk of primary progressive multiple sclerosis: A population-based case-control study
|
Alsharie, Alimohammad Mohtasham
|
|
|
51 |
C |
p.
|
artikel
|
| 64 |
The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance
|
Sandry, Joshua
|
|
|
51 |
C |
p.
|
artikel
|
| 65 |
TyPed study: Natalizumab for the treatment of pediatric-onset multiple sclerosis in Portugal
|
Palavra, Filipe
|
|
|
51 |
C |
p.
|
artikel
|
| 66 |
Underutilization of Contraception in Young Females with Demyelinating Disorders
|
Santoro, Jonathan D.
|
|
|
51 |
C |
p.
|
artikel
|
| 67 |
Use of anti-TNF-α therapy in Crohn's disease is associated with increased incidence of multiple sclerosis
|
Avasarala, Jagannadha
|
|
|
51 |
C |
p.
|
artikel
|
| 68 |
Use of cannabis in patients with multiple sclerosis from Argentina
|
Carnero Contentti, Edgar
|
|
|
51 |
C |
p.
|
artikel
|
| 69 |
Use of geographical information systems in multiple sclerosis research: A systematic scoping review
|
Hashtarkhani, Soheil
|
|
|
51 |
C |
p.
|
artikel
|
| 70 |
Willingness to be vaccinated against COVID-19: An exploratory online survey in a Portuguese cohort of multiple sclerosis patients
|
Serrazina, Filipa
|
|
|
51 |
C |
p.
|
artikel
|
Tijdschrift beschrijving